Counting Endothelial Cell Invasion

BD Biosciences-Discovery Labware's BD BioCoat™ Angiogenesis System for Endothelial Cell Invasion puts an end to the repetitious plate washing, manual cell scraping, and tedious cell counting associated with traditional in vitro cell culture insert methods. Designed to be automation friendly, the patented system allows for nondestructive, real-time evaluation and quantitation of endothelial cell invasion. The BD BioCoat Angiogenesis System combines the properties of two of the Bedford, Ma

Written byWendy Gloffke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The BD BioCoat Angiogenesis System combines the properties of two of the Bedford, Mass.-based company's technologies: the BD Falcon™ HTS FluoroBlok™ and the BD Matrigel™ Matrix. The FluoroBlok inserts contain a proprietary polyethylene terephthalate membrane, with 3.0-µm pores, which is impregnated with dyes that absorb visible light from 490-700 nm with greater than 99 percent efficiency.

The Matrigel Matrix is a reconstituted basement membrane isolated from the EHS mouse sarcoma. Rich in extracellular matrix (ECM) proteins and enhancement factors, the matrix is composed of laminin, Collagen IV, enactin, and heparan sulfate proteoglycan. These ECM components both structurally and chemically support endothelial cell invasion. The FluoroBlok membrane is coated with a uniform layer of Matrigel Matrix that occludes the membrane's pores. This coating functions as a barrier analogous to the in vivo extracellular basement membrane, allowing invasive endothelial cells to penetrate the membrane while noninvasive cells are excluded.

Users place fluorescently ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies